Pharma News

Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by wi...

Biotechnology drugmaker AbbVie Inc.

Allergan PLC (NYSE.

Bristol-Myers Squibb Co said its blockbuster Opdivo immunotherapy failed to slow progression of symptoms in previously untreated patients with advanced lung cancer, a major setback expected to benefit...

Teva Pharmaceutical Industries agreed to buy a generics distribution company from Allergan for $500 million, the drug makers said Wednesday, a day after Teva completed the purchase of Allergan’s gen...

Investors tend to recoil when a company's expenses jump.

Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.

Controlling human nerve cells with electricity could treat a range of diseases including arthritis, asthma and diabetes, a new company says.

The atrial fibrillation market will expand from approximately $8 billion in 2015 to hit its peak of $11.

Most drug manufacturers respond immediately to the FDA after having their plant operations criticized in an inspection.

Japan’s Astellas has sold its U.

The therapeutics market for venous thromboembolism (VTE), a condition which comprises deep vein thrombosis and pulmonary embolism, is set to rise from $2.